Nirsevimab
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Nirsevimab, covering 2023-11-02 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab [Phase 3]